Cath Eberlein

4PUBLICATIONS
39CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 15, 2026
Targeting the chromatin modifying enzyme, KDM5C, enhances AKT inhibition response in ER+ breast cancer.

Valentina Cutano, Shanade Dunn, Sungmi Park-Chouinard

|Aug 29, 2024
Targeting IL-8 and Its Receptors in Prostate Cancer: Inflammation, Stress Response, and Treatment Resistance.

Shauna McClelland, Pamela J Maxwell, Cristina Branco

|Aug 10, 2024
Population Pharmacokinetics of Capivasertib in Patients with Advanced or Metastatic Solid Tumours.

Carlos Fernandez-Teruel, Marie Cullberg, Cath Eberlein

Pageof 1